Contact Us

New Stories

• First patient dosed in Immutep’s TACTI-004 Phase 3 non-small cell lung cancer trial

  March 25, 2025 - - Latest News

• Chimeric announces US patent allowed for CHM CDH17 technology

  March 25, 2025 - - Latest News

• Nanotechnology could improve odds in treating aggressive breast cancers

  March 25, 2025 - - Latest News

• Noxopharm expands collaboration with Hudson Institute

  March 25, 2025 - - Latest News

• Opthea now managing the fallout of clinical trial result

  March 25, 2025 - - Latest News

• Immutep confirms presentation of pivotal TACTI-004 trial at major international meeting

  March 20, 2025 - - Latest News

• Osteopore enhances strategic refocus with early cessation of dental grant project

  March 20, 2025 - - Latest News